JOINT PAIN INJECTIONS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Joint Pain Injections Market, By Injection Type (Corticosteroid Injection, Hyaluronic Acid Injection, Platelet Rich Plasma Injection, and Others), By Joint Type (Knee and Ankle, Hip Joint, Hand and Wrist, and Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

Published In : May 2024
Code : CMI6939
Pages :179
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Increasing Product Approvals by Regulatory Authorities

Joint Pain Injections Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Increasing product approvals by regulatory authorities is expected to drive the market growth over the forecast period. For instance, in March 2021, Ono Pharmaceutical Co., Ltd., a pharmaceutical company, and SEIKAGAKU CORPORATION, a biopharmaceutical company, announced that the Ministry of Health, Labour and Welfare (MHLW) approved JOYCLU 30mg Intra-articular Injection in Japan indicated for the treatment of osteoarthritis (knee joint and hip joint).

Key Players Insights